UPMC

 

UPMC
T

Uncommon EGFR Mutations in NSCLC: Treatment, Targeted Therapy, and Clinical Trials

By UPMC FEATURING Timothy Burns
By UPMC FEATURING Timothy Burns
0 views
October 6, 2021
Comments 0
Login to view comments. Click here to Login
Videos
02:19
ecancer

ASCO® 2023 Insights: "KEYNOTE-716 Results on Pembro Use in Stag…

Feat. J. Luke
05:34
SABCS 2022 Conference Coverage

SABCS 2022 Identifying Drivers of 1L HR+/HER2- mBC Treatment Choices

Feat. A. Brufsky
08:59
UPMC

Adjuvant Treatment of High-Risk Melanoma: What Is the Future?

Feat. J. Luke
16:44
UPMC

Uncommon EGFR Mutations in NSCLC: Treatment, Targeted Therapy, and C…

Feat. T. Burns
13:27
UPMC

What Are the Medical Treatments for Obesity?

Feat. C. C. Thompson
54:41
UPMC

2020 Update on Foregut Endoscopy Surgery: What Are the Conditions, P…

Feat. C. C. Thompson
46:11
UPMC

2020 Update on Cirrhosis: What Are the New Diagnostic / Management S…

Feat. G. Garcia-Tsao